RDSMY

Royal DSM NV

 
Sponsored ADR (1 ADS : 0.25 Ordinary) International Reporting
OTCQX International Premier
Verified Company Profile 9/28/2017
Contact Info
  • Het Overloon 1
  • Heerlen TE NL-6411
  • Netherlands

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: Euronext Amsterdam
Audited Financials Audited
Latest Report Jun 30, 2017 Quarterly Report
CIK 0001339422
Fiscal Year End 12/31
OTC Marketplace OTCQX International Premier
Profile Data
SIC - Industry Classification 2800 - Chemicals & Allied Products
Incorporated In: Netherlands
Year of Inc. 1902
Employees 23500 a/o Dec 31, 2012
Company Officers/Contacts
Feike Sijbesma CEO
Rob Routs Chairman of the Supervisory Board
Gerald Matchett CFO
Sandra Segers IR
Company Directors
Feike Sijbesma Chairman
Service Providers
Accounting/Auditing Firm
Ernst & Young LLP
Sweden
 
Securities Counsel

Not Available
Investor Relations Firm

Not Available
Company History
  • Sponsored for OTCQX by Deutsche Bank Trust Company Americas on 8/6/2013
  • Formerly=DSM N.V. until 3-06
RDSMY Security Details
Share Structure
Market Value1 $14,930,220,000 a/o Oct 19, 2017
Authorized Shares 330,960,000 a/o Dec 31, 2015
Outstanding Shares 174,500,000 a/o Jun 30, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 173,159,282 a/o Dec 31, 2015
Par Value No Par Value
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
DSM - Euronext Amsterdam - Qualified
Short Selling Data
Short Interest 36,791 (14.63%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security